Matches in Nanopublications for { ?s ?p "[ETA R antagonism with atrasentan reduced cell proliferation by 16% in papillary carcinoma cells (P < 0.05) and by 51% in follicular carcinoma cells (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[ETA R antagonism with atrasentan reduced cell proliferation by 16% in papillary carcinoma cells (P < 0.05) and by 51% in follicular carcinoma cells (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ETA R antagonism with atrasentan reduced cell proliferation by 16% in papillary carcinoma cells (P < 0.05) and by 51% in follicular carcinoma cells (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP365283.RAYkox8XbrszJHCX0mVcwqXOPeS0DCQg1wP7nLJuDfxIk130_assertion description "[ETA R antagonism with atrasentan reduced cell proliferation by 16% in papillary carcinoma cells (P < 0.05) and by 51% in follicular carcinoma cells (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP365283.RAYkox8XbrszJHCX0mVcwqXOPeS0DCQg1wP7nLJuDfxIk130_provenance.
- NP614602.RAcYS1DjBqN4LDPgn66Mk6s5pFqXmb78tnd_cZ2tu7LbQ130_assertion description "[ETA R antagonism with atrasentan reduced cell proliferation by 16% in papillary carcinoma cells (P < 0.05) and by 51% in follicular carcinoma cells (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614602.RAcYS1DjBqN4LDPgn66Mk6s5pFqXmb78tnd_cZ2tu7LbQ130_provenance.
- NP365469.RAOZIUeHzyrsl8zOnYI2YvpjCGqQkNYWZOg4mDZkFYimc130_assertion description "[ETA R antagonism with atrasentan reduced cell proliferation by 16% in papillary carcinoma cells (P < 0.05) and by 51% in follicular carcinoma cells (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP365469.RAOZIUeHzyrsl8zOnYI2YvpjCGqQkNYWZOg4mDZkFYimc130_provenance.
- NP614603.RA3PVkrJCwGRKdS15nAiV-ZjbMFlC09Gabl7Vq1XHRiqk130_assertion description "[ETA R antagonism with atrasentan reduced cell proliferation by 16% in papillary carcinoma cells (P < 0.05) and by 51% in follicular carcinoma cells (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614603.RA3PVkrJCwGRKdS15nAiV-ZjbMFlC09Gabl7Vq1XHRiqk130_provenance.